Related Experiment Video

Updated: Apr 3, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K

[Safety cell therapeutics/cell based medicinal products (CBMP)]

Jürgen Scherer1, Rainer Seitz2

  • 1Fachgebiet Arzneimittel für neuartige Therapien, Gewebezubereitungen, Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, Paul-Ehrlich-Str. 51-59, 63225, Langen, Deutschland. schju@pei.de.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|September 23, 2015
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

5.3K
Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
08:05

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

Published on: June 10, 2016

11.1K

Related Experiment Videos

Last Updated: Apr 3, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

5.3K
Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
08:05

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

Published on: June 10, 2016

11.1K

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

352
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
352
Cell Lines01:16

Cell Lines

11.2K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
11.2K

Articles linked to this work by shared authors, journal, and citation graph.

Viral sepsis - pathophysiology and disease manifestation.

Infection·2025

COVID-19: A case for plasma derived natural anticoagulants?

Biologicals : journal of the International Association of Biological Standardization·2024

Thromboinflammation in COVID-19: Can α2 -macroglobulin help to control the fire?

Journal of thrombosis and haemostasis : JTH·2020

Evaluation of the in vitro Function of Platelet Concentrates from Pooled Buffy Coats or Apheresis.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2020

Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies.

Haematologica·2020

Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-B.

British journal of haematology·2015

[Health status of older people in long-term inpatient care-a narrative review].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026

[Quality of relationships among the oldest old in Germany-an examination of the association with depressive symptoms and loneliness].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026

[Modifiable risk and protective factors for dementia: an overview of established and emerging evidence].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026

[Artificial intelligence and occupational participation in Germany: a narrative review].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026

[The role of medical care centres in outpatient healthcare for adults with disabilities-a qualitative case study of two medical care centres].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026

[Data on disability, health and participation in Germany-an update].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026

Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.

Neuro-oncology·2026

[Advances in multi-omics research on methamphetamine-induced neurotoxicity and addiction].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026

Using the UTAUT model to understand HIV-negative MSM's intention to use a proposed HIV prevention mHealth management system: A cross-sectional study.

Digital health·2026

Discovery of thienopyrimidine analog G-18 as a novel anti-trichomonal agent.

International journal for parasitology. Drugs and drug resistance·2026

Tissue-specific molecular responses to salinomycin and their modulation by ionophore-antibiotic interactions in turkeys.

Poultry science·2026

Subthreshold early white-matter hyperintensity increase predicts accelerated hippocampal and whole-brain atrophy in anti-amyloid-β immunotherapy.

Journal of Alzheimer's disease : JAD·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us